|
WO2021048830A1
|
|
Atp-based cell sorting and hyperproliferative cancer stem cells
|
|
WO2021024208A1
|
|
Tpp-derivatives for mitochondria-targeted cancer therapies
|
|
WO2020264246A1
|
|
Carbocyanine compounds for targeting mitochondria and eradicating cancer stem cells
|
|
WO2020242857A1
|
|
Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
|
|
WO2020214754A1
|
|
Alkyl-tpp compounds for mitochondria targeting and anti-cancer treatments
|
|
WO2020131696A1
|
|
Triple combination therapies for targeting mitochondria and killing cancer stem cells
|
|
WO2020131704A1
|
|
Triple combination therapies for anti-aging
|
|
CA3114888A1
|
|
Azithromycin and roxithromycin derivatives as senolytic drugs
|
|
WO2019246173A1
|
|
"energetic" cancer stem cells (e-cscs): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy
|
|
WO2019232161A1
|
|
Biomarkers and therapeutics for endocrine therapy resistance
|
|
WO2019126179A1
|
|
Targeting mitochondrial fission through mdivi-1 derivatives
|
|
EP3717015A1
|
|
Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
|
|
CN111971040A
|
|
Triphenylphosphonium derivative compounds for the eradication of cancer stem cells
|
|
CR20200218A
|
|
Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
|
|
CA3078791A1
|
|
Anti-mitochondrial inhibitors for oncogenic ras and myc
|
|
US2020255902A1
|
|
Companion diagnostics for mitochondrial inhibitors
|
|
PE20200605A1
|
|
ANTIMITOSKINES: SPECIFIC INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO ERADICATE CANCER STEM CELLS
|
|
US2020046740A1
|
|
Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
|
|
EP3612187A1
|
|
Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
|
|
PE20191485A1
|
|
MITORRIBOSCINAS: THERAPEUTIC COMPOUNDS BASED ON MITOCHONDRIA THAT TARGET CANCER CELLS, BACTERIA AND PATHOGENIC YEAST
|
